This trial is active, not recruiting.

Condition hypertension
Treatment health education, home blood pressure monitoring
Sponsor Universidad de Granada
Start date February 2010
End date September 2011
Trial size 140 participants
Trial identifier NCT01233193, DMM01-FAR-10


The purpose of the study is to test if a Pharmacist Intervention Program with home blood pressure monitoring (HBPM) improves or controls pharmacological adherence and blood pressure levels in hypertensive patients under pharmacological treatment, compared to those who receive usual care in a community pharmacy setting.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation non-randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose supportive care
The intervention group receive an pharmacist intervention (health education, Home Blood Pressure Monitoring and Referral to physician as needed) This group will be followed for 6 months
health education, home blood pressure monitoring pharmaceutical health education
Health education (on hypertension, smoking, healthy diet, obesity, physical inactivity and adherence to antihypertensive medications and home blood pressure monitoring) . The patient will be referred to physician when needed. The patient will be followed up during 6 months.
(No Intervention)
The control group receive usual care in the community pharmacy

Primary Outcomes

blood pressure control
time frame: At 6 months

Secondary Outcomes

time frame: At 6 months

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Patients of both genders between the ages of 18 and 80 years, who access the pharmacy to fill their own prescription for hypertension. Exclusion criteria: - Patient living with an other Hypertensive patient treated with the same medications - Pregnant women - Hypertensive patients with levels of systolic/diastolic blood pressure ≥ 180mmHg/110mmHg - Patient with secondary hypertension, kidney or liver failure - Patients already included in a care program for hypertensive patients - Patients with a new treatment for hypertension (less than 1 month)

Additional Information

Official title Pharmacist Intervention Effect on the Medication Adherence and Blood Pressure Control in Treated Patients
Description Hypertension is a major health concern worldwide due to its deleterious impact on the population in terms of excessive morbidity and mortality, especially when there is insufficient hypertension control and prevention at the community level.
Trial information was received from ClinicalTrials.gov and was last updated in May 2016.
Information provided to ClinicalTrials.gov by Universidad de Granada.